{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:37:55Z","timestamp":1784950675649,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,28]]},"DOI":"10.7759\/cureus.61244","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T17:44:36Z","timestamp":1716918276000},"source":"Crossref","is-referenced-by-count":6,"title":["A Review of Pseudomyxoma Peritonei: Insights Into Diagnosis, Management, and Prognosis"],"prefix":"10.7759","author":[{"given":"Siddhi","family":"Shringi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin","family":"Gadkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/1319-1683.71993","article-title":"Psuedomyxoma peritonei secondary to adenocarcinoma of the cecum","volume":"17","author":"Al-Buainain H","year":"2010","unstructured":"Al-Buainain H, Al-Jehani Y, Moghazy K, Al-Quorain A. Psuedomyxoma peritonei secondary to adenocarcinoma of the cecum. J Family Community Med. 2010, 17:103-6. 10.4103\/1319-1683.71993","journal-title":"J Family Community Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2017.1310938","article-title":"Pseudomyxoma peritonei: natural history and treatment","volume":"33","author":"Mittal R","year":"2017","unstructured":"Mittal R, Chandramohan A, Moran B. Pseudomyxoma peritonei: natural history and treatment. Int J Hyperthermia. 2017, 33:511-9. 10.1080\/02656736.2017.1310938","journal-title":"Int J Hyperthermia"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5582\/irdr.2012.v1.3.115","article-title":"Pseudomyxoma peritonei as an intractable disease and its preoperative assessment to help improve prognosis after surgery: a review of the literature","volume":"1","author":"Zhong Y","year":"2012","unstructured":"Zhong Y, Deng M, Xu R, Kokudo N, Tang W. Pseudomyxoma peritonei as an intractable disease and its preoperative assessment to help improve prognosis after surgery: a review of the literature. Intractable Rare Dis Res. 2012, 1:115-21. 10.5582\/irdr.2012.v1.3.115","journal-title":"Intractable Rare Dis Res"},{"key":"ref4","article-title":"Peritoneal Cancer","author":"Anwar A","year":"2024","unstructured":"Anwar A, Kasi A. Peritoneal Cancer. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref5","unstructured":"Pseudomyxoma peritonei. (2019). Accessed. May 8, 2024: https:\/\/rarediseases.org\/rare-diseases\/pseudomyxoma-peritonei\/."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6757524","article-title":"Gastrointestinal tract disorders in older age","volume":"2019","author":"Dumic I","year":"2019","unstructured":"Dumic I, Nordin T, Jecmenica M, Stojkovic Lalosevic M, Milosavljevic T, Milovanovic T. Gastrointestinal tract disorders in older age. Can J Gastroenterol Hepatol. 2019, 2019:6757524. 10.1155\/2019\/6757524","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.21873\/cdp.10308","article-title":"Pseudomyxoma peritonei: a challenging clinical diagnosis. Case report and review of the literature","volume":"4","author":"Tsoukalas N","year":"2024","unstructured":"Tsoukalas N, Tsapakidis K, Tolia M, et al.. Pseudomyxoma peritonei: a challenging clinical diagnosis. Case report and review of the literature. Cancer Diagn Progn. 2024, 4:198-203. 10.21873\/cdp.10308","journal-title":"Cancer Diagn Progn"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23425","article-title":"Incidental diagnosis of pseudomyxoma peritonei: a case report","volume":"14","author":"Sarpietro G","year":"2022","unstructured":"Sarpietro G, Iraci Sareri M, Bonanno GM, Matarazzo MG, Cianci A. Incidental diagnosis of pseudomyxoma peritonei: a case report. Cureus. 2022, 14:e23425. 10.7759\/cureus.23425","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1590\/0100-3984.2019.0044","article-title":"The many faces of pseudomyxoma peritonei: a radiological review based on 30 cases","volume":"52","author":"Fonseca C","year":"2019","unstructured":"Fonseca C, Carvalho S, Cunha TM, Gil RT, Abecasis N. The many faces of pseudomyxoma peritonei: a radiological review based on 30 cases. Radiol Bras. 2019, 52:372-7. 10.1590\/0100-3984.2019.0044","journal-title":"Radiol Bras"},{"key":"ref10","article-title":"Pseudomyxoma Peritonei","author":"Yu B","year":"2024","unstructured":"Yu B, Raj MS. Pseudomyxoma Peritonei. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2011.01.033","article-title":"Ultrasonography findings and tumour quantification in patients with pseudomyxoma peritonei","volume":"81","author":"Krause J","year":"2012","unstructured":"Krause J, Bergman A, Graf W, Nilsson A, Mahteme H. Ultrasonography findings and tumour quantification in patients with pseudomyxoma peritonei. Eur J Radiol. 2012, 81:648-51. 10.1016\/j.ejrad.2011.01.033","journal-title":"Eur J Radiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2017.1284896","article-title":"Diagnosis of pseudomyxoma peritonei via endoscopic ultrasound guided fine needle aspiration: a case report and review of literature","volume":"52","author":"Darr U","year":"2017","unstructured":"Darr U, Renno A, Alkully T, et al.. Diagnosis of pseudomyxoma peritonei via endoscopic ultrasound guided fine needle aspiration: a case report and review of literature. Scand J Gastroenterol. 2017, 52:609-12. 10.1080\/00365521.2017.1284896","journal-title":"Scand J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12653","article-title":"Carbonic anhydrase II: a novel biomarker for pseudomyxoma peritonei","volume":"125","author":"J\u00e4rvinen P","year":"2017","unstructured":"J\u00e4rvinen P, Kivel\u00e4 AJ, Nummela P, Lepist\u00f6 A, Ristim\u00e4ki A, Parkkila S. Carbonic anhydrase II: a novel biomarker for pseudomyxoma peritonei. APMIS. 2017, 125:207-12. 10.1111\/apm.12653","journal-title":"APMIS"},{"key":"ref14","article-title":"Circulating microRNAs as possible biomarkers for coronary artery disease: a narrative review","volume":"30","author":"Melak T","year":"2019","unstructured":"Melak T, Baynes HW. Circulating microRNAs as possible biomarkers for coronary artery disease: a narrative review. EJIFCC. 2019, 30:179-94.","journal-title":"EJIFCC"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/145749691009900406","article-title":"Clinical presentation of pseudomyxoma peritonei","volume":"99","author":"J\u00e4rvinen P","year":"2010","unstructured":"J\u00e4rvinen P, Lepist\u00f6 A. Clinical presentation of pseudomyxoma peritonei. Scand J Surg. 2010, 99:213-6. 10.1177\/145749691009900406","journal-title":"Scand J Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-010-1835-0","article-title":"The accuracy of the preoperative diagnosis in women undergoing emergent gynecological laparoscopy for acute abdominal pain","volume":"284","author":"Peled Y","year":"2011","unstructured":"Peled Y, Ben-Haroush A, Eitan R, Eiger M, Pardo J, Krissi H. The accuracy of the preoperative diagnosis in women undergoing emergent gynecological laparoscopy for acute abdominal pain. Arch Gynecol Obstet. 2011, 284:1439-42. 10.1007\/s00404-010-1835-0","journal-title":"Arch Gynecol Obstet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.21037\/qims-21-976","article-title":"Enhanced computed tomography imaging features predict tumor grade in pseudomyxoma peritonei","volume":"12","author":"Sun P","year":"2022","unstructured":"Sun P, Li X, Wang L, Wang R, Du X. Enhanced computed tomography imaging features predict tumor grade in pseudomyxoma peritonei. Quant Imaging Med Surg. 2022, 12:2321-31. 10.21037\/qims-21-976","journal-title":"Quant Imaging Med Surg"},{"key":"ref18","unstructured":"Johns Hopkins Medicine. Cytology. (2019). Accessed. May 8, 2024: https:\/\/www.hopkinsmedicine.org\/health\/treatment-tests-and-therapies\/cytology."},{"key":"ref19","unstructured":"Cleveland Clinic. Cytology. (2021). Accessed. May 8, 2024: https:\/\/my.clevelandclinic.org\/health\/diagnostics\/21714-cytology."},{"key":"ref20","unstructured":"An overview of histopathology. (2024). Accessed. March 18, 2024: https:\/\/www.verywellhealth.com\/histopathology-2252152."},{"key":"ref21","unstructured":"Histopathological and cytological examination in small mammals - possibilities and limitations. (2022). Accessed. May 8, 2024: https:\/\/laboklin.com\/en\/histopathological-and-cytological-examination-in-small-mammals-possibilities-and-limitations\/."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1515\/med-2017-0020","article-title":"Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: a meta-analysis","volume":"12","author":"Guo J","year":"2017","unstructured":"Guo J, Yu J, Song X, Mi H. Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: a meta-analysis. Open Med (Wars). 2017, 12:131-7. 10.1515\/med-2017-0020","journal-title":"Open Med (Wars)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10250","article-title":"Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene","volume":"98","author":"Yin BW","year":"2002","unstructured":"Yin BW, Dnistrian A, Lloyd KO. Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene. Int J Cancer. 2002, 98:737-40. 10.1002\/ijc.10250","journal-title":"Int J Cancer"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061495","article-title":"Improved outcome prediction for appendiceal pseudomyxoma peritonei by integration of cancer cell and stromal transcriptional profiles","volume":"12","author":"Isella C","year":"2020","unstructured":"Isella C, Vaira M, Robella M, et al.. Improved outcome prediction for appendiceal pseudomyxoma peritonei by integration of cancer cell and stromal transcriptional profiles. Cancers (Basel). 2020, 12:1495. 10.3390\/cancers12061495","journal-title":"Cancers (Basel)"},{"key":"ref25","unstructured":"What are some of the factors that can impact the prognosis for PMP?. (2023). Accessed. May 8, 2024: https:\/\/www.pseudomyxomasurvivor.org\/faq-what-are-some-of-the-factors-that-can-impact-the-prognosis-for-pmp\/."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2013.1408","article-title":"Clinicopathological features and prognosis of pseudomyxoma peritonei","volume":"7","author":"Wang H","year":"2014","unstructured":"Wang H, Wang X, Ju Y, et al.. Clinicopathological features and prognosis of pseudomyxoma peritonei. Exp Ther Med. 2014, 7:185-90. 10.3892\/etm.2013.1408","journal-title":"Exp Ther Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7101","article-title":"A nomogram prediction model of pseudomyxoma peritonei established based on new prognostic factors of HE stained pathological images analysis","volume":"13","author":"Ma R","year":"2024","unstructured":"Ma R, Su YD, Yan FC, Lin YL, Gao Y, Li Y. A nomogram prediction model of pseudomyxoma peritonei established based on new prognostic factors of HE stained pathological images analysis. Cancer Med. 2024, 13:e7101. 10.1002\/cam4.7101","journal-title":"Cancer Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-017-6275-7","article-title":"Prediction of resectability in pseudomyxoma peritonei with a new CT score","volume":"25","author":"Bouquot M","year":"2018","unstructured":"Bouquot M, Dohan A, Gayat E, et al.. Prediction of resectability in pseudomyxoma peritonei with a new CT score. Ann Surg Oncol. 2018, 25:694-701. 10.1245\/s10434-017-6275-7","journal-title":"Ann Surg Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2019.12.008","article-title":"Pathological prognostic factors of pseudomyxoma peritonei: comprehensive clinicopathological analysis of 155 cases","volume":"97","author":"Yan F","year":"2020","unstructured":"Yan F, Lin Y, Zhou Q, Chang H, Li Y. Pathological prognostic factors of pseudomyxoma peritonei: comprehensive clinicopathological analysis of 155 cases. Hum Pathol. 2020, 97:9-18. 10.1016\/j.humpath.2019.12.008","journal-title":"Hum Pathol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-14765-y","article-title":"Prognostic prediction of preoperative nutritional status in low-grade appendiceal mucinous neoplasms","volume":"12","author":"Wang B","year":"2022","unstructured":"Wang B, Ma R, Shi G, et al.. Prognostic prediction of preoperative nutritional status in low-grade appendiceal mucinous neoplasms. Sci Rep. 2022, 12:10678. 10.1038\/s41598-022-14765-y","journal-title":"Sci Rep"},{"key":"ref31","unstructured":"Treatment for pseudomyxoma peritonei. (2022). Accessed. May 8, 2024: https:\/\/www.cancerresearchuk.org\/about-cancer\/pseudomyxoma-peritonei\/treatment."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6898-3","article-title":"ASO Author Reflections: quality of life after HIPEC for pseudomyxoma peritonei","volume":"25","author":"Stearns AT","year":"2018","unstructured":"Stearns AT, O'Dwyer ST. ASO Author Reflections: quality of life after HIPEC for pseudomyxoma peritonei. Ann Surg Oncol. 2018, 25:739-40. 10.1245\/s10434-018-6898-3","journal-title":"Ann Surg Oncol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/8137209","article-title":"The quality of life of pseudomyxoma peritonei patients: a scoping review","volume":"2024","author":"Taher R","year":"2024","unstructured":"Taher R, Gray D, Ramage J. The quality of life of pseudomyxoma peritonei patients: a scoping review. Eur J Cancer Care. 2024, 2024:8137209. 10.1155\/2024\/8137209","journal-title":"Eur J Cancer Care"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-12691-x","article-title":"Functional outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a prospective cohort study","volume":"30","author":"Makker PG","year":"2023","unstructured":"Makker PG, Koh CE, Ansari N, Gonzaga N, Bartyn J, Solomon M, Steffens D. Functional outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a prospective cohort study. Ann Surg Oncol. 2023, 30:447-58. 10.1245\/s10434-022-12691-x","journal-title":"Ann Surg Oncol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192114474","article-title":"Patients\u2019 desire for psychological support when receiving a cancer diagnostic","volume":"19","author":"Blasco T","year":"2022","unstructured":"Blasco T, Jovell E, Mirapeix R, Leon C. Patients\u2019 desire for psychological support when receiving a cancer diagnostic. Int J Environ Res Public Health. 2022, 19:14474. 10.3390\/ijerph192114474","journal-title":"Int J Environ Res Public Health"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13235965","article-title":"Novel perspectives in pseudomyxoma peritonei treatment","volume":"13","author":"Sommariva A","year":"2021","unstructured":"Sommariva A, Tonello M, Rigotto G, Lazzari N, Pilati P, Calabr\u00f2 ML. Novel perspectives in pseudomyxoma peritonei treatment. Cancers (Basel). 2021, 13:5965. 10.3390\/cancers13235965","journal-title":"Cancers (Basel)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01723-6","article-title":"Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines","volume":"16","author":"Lin YL","year":"2021","unstructured":"Lin YL, Xu DZ, Li XB, Yan FC, Xu HB, Peng Z, Li Y. Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines. Orphanet J Rare Dis. 2021, 16:85. 10.1186\/s13023-021-01723-6","journal-title":"Orphanet J Rare Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-022-00864-3","article-title":"Molecular targeted therapy for anticancer treatment","volume":"54","author":"Min HY","year":"2022","unstructured":"Min HY, Lee HY. Molecular targeted therapy for anticancer treatment. Exp Mol Med. 2022, 54:1670-94. 10.1038\/s12276-022-00864-3","journal-title":"Exp Mol Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16081446","article-title":"Ovarian causes of pseudomyxoma peritonei (PMP)\u2014a literature review","volume":"16","author":"Ionescu S","year":"2024","unstructured":"Ionescu S, Marincas M, Madge OL, et al.. Ovarian causes of pseudomyxoma peritonei (PMP)\u2014a literature review. Cancers (Basel). 2024, 16:1446. 10.3390\/cancers16081446","journal-title":"Cancers (Basel)"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.774005","article-title":"The impact of disease registries on advancing knowledge and understanding of dementia globally","volume":"14","author":"Heikal SA","year":"2022","unstructured":"Heikal SA, Salama M, Richard Y, Moustafa AA, Lawlor B. The impact of disease registries on advancing knowledge and understanding of dementia globally. Front Aging Neurosci. 2022, 14:774005. 10.3389\/fnagi.2022.774005","journal-title":"Front Aging Neurosci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1142\/S2339547818300020","article-title":"The growing role of precision and personalized medicine for cancer treatment","volume":"6","author":"Krzyszczyk P","year":"2018","unstructured":"Krzyszczyk P, Acevedo A, Davidoff EJ, et al.. The growing role of precision and personalized medicine for cancer treatment. Technology (Singap World Sci). 2018, 6:79-100. 10.1142\/S2339547818300020","journal-title":"Technology (Singap World Sci)"},{"key":"ref42","article-title":"Preoperative evaluation of the surgical patient","volume":"113","author":"O'Donnell FT","year":"2016","unstructured":"O'Donnell FT. Preoperative evaluation of the surgical patient. Mo Med. 2016, 113:196-201.","journal-title":"Mo Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-S1-23","article-title":"The importance of supportive care in optimizing treatment outcomes of patients with advanced prostate cancer","volume":"17","author":"Scott\u00e9 F","year":"2012","unstructured":"Scott\u00e9 F. The importance of supportive care in optimizing treatment outcomes of patients with advanced prostate cancer. Oncologist. 2012, 17:23-30. 10.1634\/theoncologist.2012-S1-23","journal-title":"Oncologist"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082204","article-title":"Recent advances with precision medicine treatment for breast cancer including triple-negative sub-type","volume":"15","author":"Subhan MA","year":"2023","unstructured":"Subhan MA, Parveen F, Shah H, Yalamarty SS, Ataide JA, Torchilin VP. Recent advances with precision medicine treatment for breast cancer including triple-negative sub-type. Cancers (Basel). 2023, 15:2204. 10.3390\/cancers15082204","journal-title":"Cancers (Basel)"},{"key":"ref45","article-title":"Therapeutic impact of determination of RAS mutations in the plasma of patient with colorectal cancer","volume":"15","author":"Macedo F","year":"2022","unstructured":"Macedo F, Monteiro J, Pereira TC, Monteiro AR, Felix Soares R, Bonito N, Sousa G. Therapeutic impact of determination of RAS mutations in the plasma of patient with colorectal cancer. Gastroenterol Hepatol Bed Bench. 2022, 15:93-8.","journal-title":"Gastroenterol Hepatol Bed Bench"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/256468-a-review-of-pseudomyxoma-peritonei-insights-into-diagnosis-management-and-prognosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T17:44:45Z","timestamp":1716918285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/256468-a-review-of-pseudomyxoma-peritonei-insights-into-diagnosis-management-and-prognosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":45,"URL":"https:\/\/doi.org\/10.7759\/cureus.61244","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,28]]}}}